Hungary

Hungary

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.4 (0.10 - 1) 2009 Survey/reported Treso B, 2012
0.45 (0.19 - 0.96) 2015 Modelled WHO
0.4 (0.40 - 0.50) 2016 Modelled Razavi-Shearer et al, 2018
0.4 (0.10 - 1) 2009 Survey/reported ECDC
0.53 (0.46 - 0.61) 2013 Modelled Schweitzer et al, 2015
0.68 (0.63 - 0.74) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.79 (0.73 - 0.86) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.79 (0.73 - 0.86) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.8 (0.73 - 0.87) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.8 (0.73 - 0.88) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.74 - 0.89) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.74 - 0.89) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.82 (0.75 - 0.90) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.82 (0.75 - 0.91) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.83 (0.75 - 0.92) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.84 (0.76 - 0.93) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.84 (0.76 - 0.94) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.85 (0.77 - 0.95) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.86 (0.77 - 0.96) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.87 (0.78 - 0.97) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.88 (0.79 - 0.99) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.9 (0.80 - 1.01) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.91 (0.81 - 1.02) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.92 (0.81 - 1.04) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.93 (0.82 - 1.05) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.94 (0.82 - 1.07) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.95 (0.83 - 1.08) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.96 (0.84 - 1.09) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.96 (0.84 - 1.10) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.85 - 1.10) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.96 (0.84 - 1.10) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.96 (0.84 - 1.09) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.96 (0.84 - 1.09) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.96 (0.84 - 1.09) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.95 (0.83 - 1.08) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.78 (0.72 - 0.86) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.44 (0.18 - 0.97) 2015 Modelled WHO
0.22 (0.16 - 0.30) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.31 (0.22 - 0.42) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.31 (0.23 - 0.41) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.31 (0.23 - 0.41) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.31 (0.22 - 0.40) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.3 (0.22 - 0.41) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.3 (0.22 - 0.41) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.31 (0.22 - 0.41) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.31 (0.22 - 0.42) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.31 (0.22 - 0.42) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.31 (0.22 - 0.42) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.31 (0.23 - 0.42) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.31 (0.23 - 0.42) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.32 (0.23 - 0.42) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.32 (0.23 - 0.42) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.32 (0.23 - 0.42) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.32 (0.23 - 0.42) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.32 (0.24 - 0.42) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.32 (0.24 - 0.42) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.33 (0.24 - 0.42) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.33 (0.24 - 0.42) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.33 (0.25 - 0.43) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.34 (0.25 - 0.44) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.35 (0.26 - 0.45) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.36 (0.26 - 0.46) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.36 (0.26 - 0.47) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.36 (0.26 - 0.47) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.36 (0.26 - 0.47) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.36 (0.26 - 0.47) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.35 (0.26 - 0.47) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.35 (0.26 - 0.47) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.9 (0.60 - 1.33) 2020 Modelled WHO
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
2.2 2015 Survey/reported ECDC
0.45 2011 Survey/reported EMCDDA
0.74 2009 Survey/reported EMCDDA
0.51 2008 Survey/reported EMCDDA
0.35 2007 Survey/reported EMCDDA
1.33 2006 Survey/reported EMCDDA
Showing out of
Show more
People who have ever injected drugs (PWID)
Download
Value (%) Year Type Source
2.2 2015 Survey/reported EMCDDA
Prisoners
Download
Value (%) Year Type Source
1.5 (1.20 - 1.80) 2009 Survey/reported Treso B et al, 2012
1.5 2012 Survey/reported ECDC
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
40,000 (36,000 - 44,000) 2016 Modelled Razavi-Shearer et al, 2018
65,954 (61,121 - 71,681) 2019 Modelled IHME, GBD 2019 (accessed 2020)
72,728 (66,977 - 79,702) 2019 Modelled IHME, GBD 2019 (accessed 2022)
73,605 (68,220 - 80,162) 2018 Modelled IHME, GBD 2019 (accessed 2022)
74,191 (68,305 - 80,841) 2017 Modelled IHME, GBD 2019 (accessed 2022)
74,677 (68,952 - 81,591) 2016 Modelled IHME, GBD 2019 (accessed 2022)
75,334 (68,692 - 83,043) 2015 Modelled IHME, GBD 2019 (accessed 2022)
76,097 (69,479 - 83,848) 2014 Modelled IHME, GBD 2019 (accessed 2022)
76,858 (70,060 - 84,686) 2013 Modelled IHME, GBD 2019 (accessed 2022)
77,636 (70,698 - 85,541) 2012 Modelled IHME, GBD 2019 (accessed 2022)
78,430 (71,327 - 86,518) 2011 Modelled IHME, GBD 2019 (accessed 2022)
79,278 (71,883 - 87,724) 2010 Modelled IHME, GBD 2019 (accessed 2022)
80,176 (72,716 - 88,834) 2009 Modelled IHME, GBD 2019 (accessed 2022)
81,092 (73,302 - 89,808) 2008 Modelled IHME, GBD 2019 (accessed 2022)
82,067 (74,144 - 91,128) 2007 Modelled IHME, GBD 2019 (accessed 2022)
83,100 (74,721 - 92,625) 2006 Modelled IHME, GBD 2019 (accessed 2022)
84,267 (75,444 - 94,303) 2005 Modelled IHME, GBD 2019 (accessed 2022)
85,626 (76,607 - 95,822) 2004 Modelled IHME, GBD 2019 (accessed 2022)
87,117 (77,613 - 97,648) 2003 Modelled IHME, GBD 2019 (accessed 2022)
88,629 (78,506 - 99,776) 2002 Modelled IHME, GBD 2019 (accessed 2022)
89,981 (79,400 - 101,746) 2001 Modelled IHME, GBD 2019 (accessed 2022)
91,106 (80,209 - 103,422) 2000 Modelled IHME, GBD 2019 (accessed 2022)
92,194 (80,809 - 104,602) 1999 Modelled IHME, GBD 2019 (accessed 2022)
93,359 (81,701 - 105,603) 1998 Modelled IHME, GBD 2019 (accessed 2022)
94,416 (82,543 - 107,159) 1997 Modelled IHME, GBD 2019 (accessed 2022)
95,157 (83,346 - 108,102) 1996 Modelled IHME, GBD 2019 (accessed 2022)
95,466 (83,582 - 108,932) 1995 Modelled IHME, GBD 2019 (accessed 2022)
95,469 (83,617 - 108,760) 1994 Modelled IHME, GBD 2019 (accessed 2022)
95,434 (83,586 - 108,366) 1993 Modelled IHME, GBD 2019 (accessed 2022)
95,352 (83,611 - 108,413) 1992 Modelled IHME, GBD 2019 (accessed 2022)
95,146 (83,252 - 108,154) 1991 Modelled IHME, GBD 2019 (accessed 2022)
94,778 (82,882 - 107,644) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
11.5 (8.58 - 15.30) 2019 Modelled IHME, GBD 2019 (accessed 2020)
20.51 (16.17 - 25.02) 1991 Modelled IHME, GBD 2019 (accessed 2022)
23.25 (18.26 - 28.46) 1992 Modelled IHME, GBD 2019 (accessed 2022)
19.3 (15.30 - 23.53) 1990 Modelled IHME, GBD 2019 (accessed 2022)
24.96 (19.61 - 30.48) 1993 Modelled IHME, GBD 2019 (accessed 2022)
25.37 (19.93 - 31.09) 1994 Modelled IHME, GBD 2019 (accessed 2022)
25.03 (19.54 - 30.81) 1995 Modelled IHME, GBD 2019 (accessed 2022)
22.33 (17.41 - 27.53) 1998 Modelled IHME, GBD 2019 (accessed 2022)
22.75 (17.77 - 28) 1996 Modelled IHME, GBD 2019 (accessed 2022)
22.09 (17.28 - 27.30) 1997 Modelled IHME, GBD 2019 (accessed 2022)
21.95 (17.05 - 27.07) 1999 Modelled IHME, GBD 2019 (accessed 2022)
20.29 (15.65 - 25.02) 2000 Modelled IHME, GBD 2019 (accessed 2022)
19.24 (14.98 - 23.65) 2001 Modelled IHME, GBD 2019 (accessed 2022)
18.91 (14.73 - 23.22) 2002 Modelled IHME, GBD 2019 (accessed 2022)
18.76 (14.63 - 23.10) 2003 Modelled IHME, GBD 2019 (accessed 2022)
18.16 (14.17 - 22.28) 2004 Modelled IHME, GBD 2019 (accessed 2022)
18.05 (14.03 - 22.22) 2005 Modelled IHME, GBD 2019 (accessed 2022)
17.45 (13.61 - 21.51) 2006 Modelled IHME, GBD 2019 (accessed 2022)
17.3 (13.48 - 21.34) 2007 Modelled IHME, GBD 2019 (accessed 2022)
16.27 (12.66 - 20.10) 2008 Modelled IHME, GBD 2019 (accessed 2022)
15.75 (12.23 - 19.48) 2009 Modelled IHME, GBD 2019 (accessed 2022)
14.7 (11.38 - 18.26) 2010 Modelled IHME, GBD 2019 (accessed 2022)
12.9 (9.93 - 16.18) 2012 Modelled IHME, GBD 2019 (accessed 2022)
13.71 (10.61 - 17.08) 2011 Modelled IHME, GBD 2019 (accessed 2022)
11.73 (9 - 14.67) 2014 Modelled IHME, GBD 2019 (accessed 2022)
11.95 (9.21 - 15.04) 2013 Modelled IHME, GBD 2019 (accessed 2022)
11.7 (8.96 - 14.71) 2015 Modelled IHME, GBD 2019 (accessed 2022)
11.29 (8.65 - 14.22) 2016 Modelled IHME, GBD 2019 (accessed 2022)
11.33 (8.68 - 14.27) 2017 Modelled IHME, GBD 2019 (accessed 2022)
11.62 (8.74 - 14.97) 2018 Modelled IHME, GBD 2019 (accessed 2022)
11.52 (8.58 - 15.26) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
767 2016 Modelled WHO
2,128 (1,679 - 2,596) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2,410 (1,893 - 2,949) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2,006 (1,590 - 2,445) 1990 Modelled IHME, GBD 2019 (accessed 2022)
2,582 (2,028 - 3,153) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2,620 (2,058 - 3,210) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2,580 (2,014 - 3,177) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2,342 (1,829 - 2,882) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2,244 (1,743 - 2,768) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2,289 (1,785 - 2,822) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2,270 (1,775 - 2,804) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2,070 (1,597 - 2,552) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1,959 (1,525 - 2,408) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1,921 (1,497 - 2,360) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1,837 (1,432 - 2,253) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1,901 (1,482 - 2,341) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1,756 (1,370 - 2,165) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1,738 (1,353 - 2,143) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1,821 (1,415 - 2,241) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1,630 (1,268 - 2,014) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1,575 (1,223 - 1,947) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1,465 (1,134 - 1,820) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1,362 (1,054 - 1,697) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1,277 (983 - 1,602) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1,180 (909 - 1,485) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1,155 (886 - 1,445) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1,148 (880 - 1,444) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1,105 (847 - 1,392) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1,129 (849 - 1,454) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1,105 (846 - 1,393) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1,115 (830 - 1,477) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1,115 (830 - 1,477) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
15 (10 - 20) 1991 Modelled IHME, GBD 2019 (accessed 2022)
14 (10 - 20) 1992 Modelled IHME, GBD 2019 (accessed 2022)
15 (10 - 20) 1990 Modelled IHME, GBD 2019 (accessed 2022)
14 (10 - 19) 1993 Modelled IHME, GBD 2019 (accessed 2022)
13 (9 - 18) 1994 Modelled IHME, GBD 2019 (accessed 2022)
12 (8 - 16) 1995 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 13) 1996 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 1998 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 12) 1997 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 1999 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 12) 2000 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 15) 2002 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 2001 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 16) 2003 Modelled IHME, GBD 2019 (accessed 2022)
13 (9 - 17) 2004 Modelled IHME, GBD 2019 (accessed 2022)
13 (9 - 17) 2005 Modelled IHME, GBD 2019 (accessed 2022)
13 (10 - 18) 2006 Modelled IHME, GBD 2019 (accessed 2022)
14 (10 - 19) 2007 Modelled IHME, GBD 2019 (accessed 2022)
14 (10 - 19) 2008 Modelled IHME, GBD 2019 (accessed 2022)
14 (10 - 19) 2009 Modelled IHME, GBD 2019 (accessed 2022)
13 (10 - 18) 2010 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 2012 Modelled IHME, GBD 2019 (accessed 2022)
12 (8 - 16) 2011 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 13) 2013 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 12) 2014 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 2015 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 2016 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 2017 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 2018 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 2019 Modelled IHME, GBD 2019 (accessed 2022)
20 (14 - 28) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
21 2017 Survey/reported EMCDDA, 2019
48 (32 - 91) 2016 Survey/reported Hungary National Institute for Health Development, 2016
21 2017 Survey/reported ECDC
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.5 (0.30 - 0.60) 2015 Modelled Blach et al, 2017
1.27 (1.03 - 1.56) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1.26 (1.03 - 1.55) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1.26 (1.02 - 1.54) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1.27 (1.03 - 1.54) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1.28 (1.05 - 1.56) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1.3 (1.06 - 1.57) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1.31 (1.08 - 1.59) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1.33 (1.09 - 1.61) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1.35 (1.10 - 1.63) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1.36 (1.11 - 1.66) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1.38 (1.12 - 1.68) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1.39 (1.13 - 1.70) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1.41 (1.15 - 1.72) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1.42 (1.15 - 1.74) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1.44 (1.17 - 1.76) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1.47 (1.19 - 1.79) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1.5 (1.22 - 1.83) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1.53 (1.25 - 1.86) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1.56 (1.28 - 1.90) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1.59 (1.29 - 1.93) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1.61 (1.32 - 1.96) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1.63 (1.34 - 1.98) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1.65 (1.35 - 2.01) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1.67 (1.37 - 2.03) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1.68 (1.38 - 2.05) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1.69 (1.39 - 2.06) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1.7 (1.40 - 2.07) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1.72 (1.40 - 2.08) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1.73 (1.41 - 2.09) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.74 (1.41 - 2.11) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1.21 (0.98 - 1.49) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
48.69 2014 Survey/reported EMCDDA
24.08 2011 Survey/reported EMCDDA
24.44 2009 Survey/reported EMCDDA
22.62 2008 Survey/reported EMCDDA
25.73 2007 Survey/reported EMCDDA
28.91 2006 Survey/reported EMCDDA
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.51 (0.28 - 0.54) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
0.5 (0.20 - 1.10) 2009 Survey/reported Treso B, 2012
0.8 (0.40 - 2.70) 2014 Survey/reported Gower et al, 2014
0.8 (0.40 - 2.70) 2014 Survey/reported Gower et al, 2014
0.5 (0.20 - 1.10) 2009 Survey/reported ECDC
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
46.6 (30.40 - 62.80) 2015 Modelled Degenhardt L et al, 2017
24.1 (20.80 - 27.60) 2011 Survey/reported EMCDDA
49.7 2015 Survey/reported ECDC
Showing out of
Show more
People who have ever injected drugs (PWID)
Download
Value (%) Year Type Source
49.7 2015 Survey/reported EMCDDA
Prisoners
Download
Value (%) Year Type Source
4.9 (4.30 - 5.60) 2009 Survey/reported Treso B et al, 2012
4.9 2012 Survey/reported ECDC
Showing out of
Show more
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
52,000 (29,000 - 55,000) 2015 Modelled Blach et al, 2017
173,528 (141,038 - 210,860) 1990 Modelled IHME, GBD 2019 (accessed 2022)
172,166 (140,275 - 207,068) 1991 Modelled IHME, GBD 2019 (accessed 2022)
170,620 (139,431 - 206,632) 1992 Modelled IHME, GBD 2019 (accessed 2022)
168,966 (138,546 - 205,427) 1993 Modelled IHME, GBD 2019 (accessed 2022)
167,352 (137,221 - 203,996) 1994 Modelled IHME, GBD 2019 (accessed 2022)
165,888 (135,866 - 202,956) 1995 Modelled IHME, GBD 2019 (accessed 2022)
164,325 (134,822 - 200,257) 1996 Modelled IHME, GBD 2019 (accessed 2022)
162,431 (133,365 - 197,840) 1997 Modelled IHME, GBD 2019 (accessed 2022)
160,251 (131,611 - 195,097) 1998 Modelled IHME, GBD 2019 (accessed 2022)
157,877 (129,313 - 192,685) 1999 Modelled IHME, GBD 2019 (accessed 2022)
155,505 (127,047 - 189,564) 2000 Modelled IHME, GBD 2019 (accessed 2022)
152,741 (124,864 - 186,463) 2001 Modelled IHME, GBD 2019 (accessed 2022)
149,325 (121,843 - 182,105) 2002 Modelled IHME, GBD 2019 (accessed 2022)
145,670 (118,393 - 177,672) 2003 Modelled IHME, GBD 2019 (accessed 2022)
142,235 (115,526 - 173,717) 2004 Modelled IHME, GBD 2019 (accessed 2022)
139,454 (113,023 - 170,321) 2005 Modelled IHME, GBD 2019 (accessed 2022)
137,292 (111,836 - 167,708) 2006 Modelled IHME, GBD 2019 (accessed 2022)
135,366 (110,310 - 165,308) 2007 Modelled IHME, GBD 2019 (accessed 2022)
133,614 (108,968 - 163,156) 2008 Modelled IHME, GBD 2019 (accessed 2022)
131,949 (107,247 - 160,878) 2009 Modelled IHME, GBD 2019 (accessed 2022)
130,248 (106,274 - 158,609) 2010 Modelled IHME, GBD 2019 (accessed 2022)
128,343 (104,743 - 155,882) 2011 Modelled IHME, GBD 2019 (accessed 2022)
126,226 (103,579 - 153,114) 2012 Modelled IHME, GBD 2019 (accessed 2022)
124,114 (101,991 - 150,881) 2013 Modelled IHME, GBD 2019 (accessed 2022)
122,153 (100,041 - 148,665) 2014 Modelled IHME, GBD 2019 (accessed 2022)
120,441 (98,518 - 147,122) 2015 Modelled IHME, GBD 2019 (accessed 2022)
118,688 (97,046 - 144,425) 2016 Modelled IHME, GBD 2019 (accessed 2022)
117,585 (95,532 - 143,908) 2017 Modelled IHME, GBD 2019 (accessed 2022)
117,420 (95,901 - 143,812) 2018 Modelled IHME, GBD 2019 (accessed 2022)
116,957 (94,966 - 143,818) 2019 Modelled IHME, GBD 2019 (accessed 2020)
117,528 (95,474 - 144,479) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
11,400 (6,300 - 12,100) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
6.65 (4.67 - 9.31) 2019 Modelled IHME, GBD 2019 (accessed 2020)
12.33 (9.46 - 16.12) 1991 Modelled IHME, GBD 2019 (accessed 2022)
13.78 (10.53 - 18.11) 1992 Modelled IHME, GBD 2019 (accessed 2022)
11.67 (9 - 15.17) 1990 Modelled IHME, GBD 2019 (accessed 2022)
14.64 (11.07 - 19.42) 1993 Modelled IHME, GBD 2019 (accessed 2022)
14.75 (11.18 - 19.61) 1994 Modelled IHME, GBD 2019 (accessed 2022)
14.46 (10.92 - 19.24) 1995 Modelled IHME, GBD 2019 (accessed 2022)
13 (9.70 - 17.33) 1996 Modelled IHME, GBD 2019 (accessed 2022)
12.19 (9.07 - 16.40) 1999 Modelled IHME, GBD 2019 (accessed 2022)
12.48 (9.31 - 16.75) 1998 Modelled IHME, GBD 2019 (accessed 2022)
12.49 (9.31 - 16.72) 1997 Modelled IHME, GBD 2019 (accessed 2022)
11.3 (8.39 - 15.07) 2000 Modelled IHME, GBD 2019 (accessed 2022)
10.82 (8.08 - 14.38) 2001 Modelled IHME, GBD 2019 (accessed 2022)
10.68 (7.96 - 14.14) 2002 Modelled IHME, GBD 2019 (accessed 2022)
10.66 (7.96 - 14.10) 2003 Modelled IHME, GBD 2019 (accessed 2022)
10.37 (7.80 - 13.68) 2004 Modelled IHME, GBD 2019 (accessed 2022)
10.34 (7.76 - 13.68) 2005 Modelled IHME, GBD 2019 (accessed 2022)
10.08 (7.61 - 13.33) 2006 Modelled IHME, GBD 2019 (accessed 2022)
10.06 (7.65 - 13.31) 2007 Modelled IHME, GBD 2019 (accessed 2022)
9.54 (7.25 - 12.82) 2008 Modelled IHME, GBD 2019 (accessed 2022)
9.27 (7 - 12.42) 2009 Modelled IHME, GBD 2019 (accessed 2022)
8.67 (6.54 - 11.62) 2010 Modelled IHME, GBD 2019 (accessed 2022)
7.53 (5.65 - 10.10) 2012 Modelled IHME, GBD 2019 (accessed 2022)
6.96 (5.21 - 9.33) 2013 Modelled IHME, GBD 2019 (accessed 2022)
8.08 (6.07 - 10.79) 2011 Modelled IHME, GBD 2019 (accessed 2022)
6.8 (5.06 - 9.16) 2014 Modelled IHME, GBD 2019 (accessed 2022)
6.76 (5.04 - 9.07) 2015 Modelled IHME, GBD 2019 (accessed 2022)
6.56 (4.88 - 8.94) 2017 Modelled IHME, GBD 2019 (accessed 2022)
6.53 (4.87 - 8.88) 2016 Modelled IHME, GBD 2019 (accessed 2022)
6.65 (4.67 - 9.31) 2019 Modelled IHME, GBD 2019 (accessed 2022)
6.72 (4.89 - 9.28) 2018 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
965 2016 Modelled WHO
644 (452 - 900) 2019 Modelled IHME, GBD 2019 (accessed 2022)
644 (452 - 900) 2019 Modelled IHME, GBD 2019 (accessed 2020)
653 (475 - 902) 2018 Modelled IHME, GBD 2019 (accessed 2022)
640 (476 - 872) 2017 Modelled IHME, GBD 2019 (accessed 2022)
639 (477 - 869) 2016 Modelled IHME, GBD 2019 (accessed 2022)
664 (495 - 891) 2015 Modelled IHME, GBD 2019 (accessed 2022)
669 (499 - 903) 2014 Modelled IHME, GBD 2019 (accessed 2022)
687 (515 - 922) 2013 Modelled IHME, GBD 2019 (accessed 2022)
745 (560 - 1,000) 2012 Modelled IHME, GBD 2019 (accessed 2022)
803 (603 - 1,072) 2011 Modelled IHME, GBD 2019 (accessed 2022)
864 (651 - 1,158) 2010 Modelled IHME, GBD 2019 (accessed 2022)
926 (700 - 1,242) 2009 Modelled IHME, GBD 2019 (accessed 2022)
956 (727 - 1,285) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1,010 (768 - 1,337) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1,015 (766 - 1,341) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1,043 (783 - 1,380) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1,049 (789 - 1,383) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1,080 (807 - 1,429) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1,085 (809 - 1,437) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1,101 (822 - 1,464) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1,153 (856 - 1,538) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1,247 (928 - 1,677) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1,280 (954 - 1,717) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1,283 (956 - 1,718) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1,338 (998 - 1,783) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1,491 (1,125 - 1,983) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1,524 (1,155 - 2,025) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1,515 (1,145 - 2,009) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1,428 (1,092 - 1,877) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1,280 (982 - 1,673) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1,213 (935 - 1,577) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
17 (12 - 22) 1991 Modelled IHME, GBD 2019 (accessed 2022)
16 (11 - 22) 1992 Modelled IHME, GBD 2019 (accessed 2022)
17 (12 - 22) 1990 Modelled IHME, GBD 2019 (accessed 2022)
15 (11 - 21) 1993 Modelled IHME, GBD 2019 (accessed 2022)
13 (9 - 18) 1995 Modelled IHME, GBD 2019 (accessed 2022)
15 (10 - 19) 1994 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 15) 1996 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 13) 1997 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 12) 1998 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 12) 1999 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 13) 2000 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 15) 2001 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 16) 2002 Modelled IHME, GBD 2019 (accessed 2022)
14 (10 - 18) 2004 Modelled IHME, GBD 2019 (accessed 2022)
13 (9 - 17) 2003 Modelled IHME, GBD 2019 (accessed 2022)
14 (10 - 19) 2005 Modelled IHME, GBD 2019 (accessed 2022)
15 (11 - 20) 2006 Modelled IHME, GBD 2019 (accessed 2022)
16 (11 - 21) 2007 Modelled IHME, GBD 2019 (accessed 2022)
16 (12 - 21) 2008 Modelled IHME, GBD 2019 (accessed 2022)
16 (11 - 21) 2009 Modelled IHME, GBD 2019 (accessed 2022)
15 (11 - 20) 2010 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 16) 2012 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 15) 2013 Modelled IHME, GBD 2019 (accessed 2022)
14 (10 - 19) 2011 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 2014 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 13) 2015 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 13) 2016 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 13) 2017 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 2019 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 13) 2018 Modelled IHME, GBD 2019 (accessed 2022)
26 (18 - 34) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Number of persons treated for HCV

National
Download
Value Year Type Source
838 2017 Survey/reported ECDC, 2019
838 2017 Survey/reported The European Centre for Disease Prevention and Control, 2019
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
21 2017 Survey/reported EMCDDA, 2019
48 (32 - 91) 2016 Survey/reported Hungary National Institute for Health Development, 2016
21 2017 Survey/reported ECDC
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)
Source: WHO

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
0.78 (%)
2019
(0.72 - 0.86(%))
IHME, GBD 2019 (accessed 2022)
HCV (RNA/cAg+)
1.27 (%)
2019
(1.03 - 1.56(%))
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

HBV (HBsAg+)
0.4 (%)
2009
(0.1 - 1(%))
Treso B, 2012
HCV (anti-HCV)
0.8 (%)
2014
(0.4 - 2.7(%))
Gower et al, 2014

Hepatitis related deaths (national)

Modelled

HBV
1,115
2019
(830 - 1,477)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HBV chart

Modelled

HCV
644
2019
(452 - 900)
IHME, GBD 2019 (accessed 2020)

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.90 (%)
2020, latest modelled
(0.60 - 1.33(%))
WHO

Prevalence PWID

HCV
49.70 (%)
2015, survey/surveillance
ECDC

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
21
2017
EMCDDA, 2019
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Latest news

View all

News

Resources

Programs

Partners